DESIRIAL PLUS STYLING (2x2ml) - VIVACY

Description

DESIRIAL® is the first gel based on antioxidant hyaluronic acid specially formulated to preserve the intimate health of women .

Entirely dedicated to women's intimate health, the DESIRIAL® viscosupplementation solution developed by Laboratoires Vivacy opens up new treatment options in gynecology and intimate plastic surgery.

Up to 80% of women who enter menopause are affected by vaginal dryness and approximately 50% of postmenopausal women continue to experience vaginal dryness.

Vaginal and/or vulvar dryness can affect women throughout their lives, whether iatrogenic (eg isotretinoin, tricyclic antidepressants, neuroleptics, etc.), or related to menopause, in particular in the absence of hormone replacement therapy (HRT).

During menopause, a decrease in estrogen secretion is observed, which has an effect on the fibroblasts, and leads to a progressive hypotrophy of the dermis with the flattening of the dermo-epidermal junction:

- The vaginal mucosa becomes dry (the connective tissue has less vascularization, is less hydrated and becomes thinner), just like the skin as a whole. Less nourished glandular cells become trophic and begin to malfunction.
- The skin loses its elasticity. Collagen and elastin fibers degenerate and shrink, fibroblasts become hypoactive and type III collagen increases at the expense of type I collagen.

As a result, skin dryness, loss of elasticity, and fragility appear. Falling estrogen levels (related to menopause) leads to labia majora hypotrophy, also characterized by dryness of the vulva.

The injection of DESIRIAL® cross-linked hyaluronic acid into the dermis of the lip can help rehydrate, biostimulate and restore the activity of fibroblasts and maintain the proper functioning of female genital tissues.

DESIRIAL®:
for women in the pre-menopausal period or of reproductive age with a predisposition or clear signs of moderate to severe hypotrophy of the vulva and labia majora.
Remodeling of the labia majora, the vulva.

Features

- 2 pre-filled syringes of 2ml Needles 27G1/2

- Composed of a cross-linked hyaluronic acid concentrated at 21mg/g

- IPN-Like technology which extends its duration of action

- Hyaluronic Acid stimulates the natural hydration of the skin over the long term

DESIRIAL® PLUS is a more elastic, cohesive gel capable of reshaping atrophied labia majora.
In addition, among the consequences of these aesthetic improvements, protection of the labia minora can be observed.
DESIRIAL® PLUS is used in cases of labia majora atrophy.
Indeed, from a certain age, the volume of the tissues tends to decrease.
In particular, at the level of the labia majora, this atrophy can alter the natural protection of the vulva and cause localized pain.
Hyaluronic acid recreates volume in the labia majora and thus protects the vulva.
It can correct vulvar morphological imperfections.

Targeted areas, indications:

For women in the pre-menopausal period or of reproductive age with a predisposition or overt signs of moderate to severe hypotrophy of the vulva and labia majora.
Remodeling of the labia majora, the vulva.

Reinforcement of the protective function of the labia majora through an increase in volume.

Improved aesthetic appearance of the vulvo-vaginal area

Treatment protocol

Attention ! This act must be carried out by a qualified professional.

FOR WHAT?

Treat and rebuild lip problem.

FOR WHO?

• Pre- or post-menopausal women.
• Women of childbearing age with a predisposition for or with overt signs of vulvar atrophy or enlargement.

INDICATION

• Hypotrophy, atrophy of the labia majora (loss of volume)
• Aesthetic discomfort.

RESULTS

• Reinforcement of the protective function of the labia majora induced by the increase in volume.
• Improvement of the aesthetic appearance of the vulvar region.

TECHNOLOGY

The IPN-Like technology from Laboratoires Vivacy is a unique technology, patented since 2007 and recognized for its decline in effectiveness and tolerance in the field of facial aesthetics with products from the STYLAGE® range.
This technology involves an interpenetration of two monophasic cross-linked networks of hyaluronic acid in order to stabilize the hyaluronic acid for increased persistence and easier injectability.